These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9636574)

  • 1. Immunosuppression using tacrolimus, mycophenolate, and prednisone following orthotopic liver transplantation: a single-center experience.
    Rudich SM; Riegler JL; Perez RV; Sturges MA; McVicar JP
    Transplant Proc; 1998 Jun; 30(4):1417-8. PubMed ID: 9636574
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation.
    Cai TH; Esterl RM; Nichols L; Cigarroa F; Speeg KV; Halff GA
    Transplant Proc; 1998 Jun; 30(4):1413-4. PubMed ID: 9636572
    [No Abstract]   [Full Text] [Related]  

  • 3. One hundred children treated with tacrolimus after primary orthotopic liver transplantation.
    McDiarmid S; Goss J; Seu P; Shackleton C; Vargas J; Ament M; Busuttil R
    Transplant Proc; 1998 Jun; 30(4):1397-8. PubMed ID: 9636564
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
    Jain A; Kashyap R; Kramer D; Dodson F; Hamad I; Starzl TE; Fung JJ
    Transplant Proc; 2001; 33(1-2):1342-4. PubMed ID: 11267319
    [No Abstract]   [Full Text] [Related]  

  • 5. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation.
    Gerbase MW; Spiliopoulos A; Fathi M; Nicod LP
    Transplant Proc; 2001 May; 33(3):2146-7. PubMed ID: 11377481
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.
    Klupp J; Glanemann M; Bechstein WO; Platz KP; Langrehr JM; Keck H; Settmacher U; Radtke C; Neuhaus R; Neuhaus P
    Transplant Proc; 1999; 31(1-2):1113-4. PubMed ID: 10083497
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
    Shapiro R; Jordan ML; Scantlebury VP; Vivas C; Marsh JW; McCauley J; Johnston J; Randhawa P; Irish W; Gritsch HA; Naraghi R; Hakala TR; Fung JJ; Starzl TE
    Transplant Proc; 1999; 31(1-2):1134. PubMed ID: 10083507
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation.
    Rafecas A; Lladó L; Albiol MT; Ramos E; Torras J; Fabregat J; Lama C; Busquets J; Ibáñez L; Figueras J; Jaurrieta E
    Transplant Proc; 2002 Feb; 34(1):107. PubMed ID: 11959209
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up.
    Gavlik A; Demirbas A; Tsaroucha A; Webb MG; Nery JR; Khan MF; Karatzas T; Khan RT; Zucker K; Viciana AL; Miller JA; Tzakis AG
    Transplant Proc; 1997 Nov; 29(7):2971-2. PubMed ID: 9365633
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
    Morales JM; Andrés A; Morales E; Herrero JC; Cubas A; Praga M; Hernández E; Ortuño T; Dominguez-Gil B; Carreño A; Delgado M; Manzanares C
    Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus.
    Daly I; Jain A; Reyes J; Fung J
    Transplant Proc; 2002 Aug; 34(5):1503. PubMed ID: 12176458
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation.
    Facundo C; Diaz JM; Guirado L; Duran F; Herreros MA; Diaz M; Sola R
    Transplant Proc; 2002 Feb; 34(1):98. PubMed ID: 11959203
    [No Abstract]   [Full Text] [Related]  

  • 13. A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation.
    Reggiani P; Arru M; Regazzi M; Gatti S; Molinaro MD; Caccamo L; Maggi U; Melada E; Paone G; Rossi G
    Transplant Proc; 2005 May; 37(4):1697-9. PubMed ID: 15919435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results.
    Hodge EE; Reich DJ; Clavien PA; Kim-Schluger L
    Transplant Proc; 2002 Aug; 34(5):1546-7. PubMed ID: 12176477
    [No Abstract]   [Full Text] [Related]  

  • 15. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
    [No Abstract]   [Full Text] [Related]  

  • 16. A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil.
    Ringe B; Braun F; Schütz E; Füzesi L; Lorf T; Canelo R; Oellerich M; Ramadori G
    Transplantation; 2001 Feb; 71(4):508-15. PubMed ID: 11258429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: a pilot efficacy and safety study.
    Fahlke J; Wolff S; Mantke R; Pross M; Weiss G; Buerger T; Lippert H
    Transplant Proc; 2002 Jun; 34(4):1242-4. PubMed ID: 12072328
    [No Abstract]   [Full Text] [Related]  

  • 18. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
    Hunt SA
    Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
    Ettenger R; Cohen A; Nast C; Moulton L; Marik J; Gales B
    Transplant Proc; 1997; 29(1-2):340-1. PubMed ID: 9123030
    [No Abstract]   [Full Text] [Related]  

  • 20. Steroids withdrawal after 3 months of successful renal transplantation using a tacrolimus- and mycophenolate-based immunosuppression.
    Alarcón-Zurita A; Munar MA; Losada P; Morey A; Martinez J; de la Prada FJ; Marco J
    Transplant Proc; 2002 Feb; 34(1):118-9. PubMed ID: 11959216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.